Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients

Rafael Luque; Zeid A ALOthman; Alina M Balu; Leonid Voskressensky

doi:10.3390/molecules26216738

Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients

Molecules. 2021 Nov 8;26(21):6738. doi: 10.3390/molecules26216738.

Authors

Rafael Luque^{1

2}, Zeid A ALOthman², Alina M Balu¹, Leonid Voskressensky³

Affiliations

¹ Departamento de Química Orgánica, Campus de Rabanales, Universidad de Córdoba, Edificio Marie Curie (C-3), Ctra Nnal IV-A, Km 396, 14014 Cordoba, Spain.
² Chemistry Department, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
³ Department of Chemistry, Peoples Friendship University of Russia (RUDN University), 6 Miklukho Maklaya St., 117198 Moscow, Russia.

Abstract

A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key molecule examples: Ancarolol and Furosemide.

Keywords: APIs; furanics; heterogeneous catalysis; waste-to-pharma.

Publication types

Review

MeSH terms

Alcohols / chemistry*
Catalysis
Furosemide / chemistry*
Molecular Structure

Substances

Alcohols
Furosemide

Abstract

Publication types

MeSH terms

Substances

Grants and funding